The moment a regulatory decision changes the direction of the entire program.
Critical insight, pathway creation and a precise route forward.
Regulatory strategy, problem solving and pathway creation are what we do.
Read the evidence, authority response and benefit-risk position as one system.
Identify the decision that unlocks the program rather than adding ancillary activity.
Build a defensible pathway when guidance or precedent does not exist.
Align teams and evidence around a clear route to review and approval.
Leave once the path forward is established and the program can move.
We collaborate with clients at the forefront of medical product development. Our focus is on programs receiving devastating health authority responses or needing to create a new regulatory pathway where none exists.
We do not augment staff or provide ancillary regulatory affairs services. Regulatory strategy, problem solving and pathway creation are our work.
Strategy, problem solving and pathway creation.
We provide critical insights at every step of the product development cycle across therapeutic areas and product types. We translate discoveries from the research bench and shepherd them through development challenges, avoiding pitfalls until they reach the patient at the bedside.
Staff augmentation or ancillary regulatory affairs.
Our focus is the consequential decision and the defensible path forward.
We choose the clients and programs we work with. We transform nonclinical and clinical data, create a path forward, accelerate development and then exit.
Engage where judgment matters most.
Share the regulatory decision, development challenge or pathway that needs experienced judgment.
Schedule a consultation